Viveve Medical, Inc. (NASDAQ:VIVE) is reporting third quarter financial results on Thursday 12th November 2020, after market close.
According to analysts surveyed by Thomson Reuters, VIVE is expected to report 3Q20 loss of $ 0.53 per share from revenue of $ 1.00 million.
For the full year, analysts anticipate top line of $ 4.82 million, while looking forward to loss of $ 2.41 per share bottom line.
Previous Quarter Performance
Viveve Medical, Inc. announced loss for the second quarter of $ 0.45 per share, from the revenue of $ 0.70 million. Street analysts expected Viveve Medical, Inc. to report loss of $ 0.59 per share on revenue of $ 0.53 million for the second quarter. The bottom line results beat street analysts by $ 0.14 or 23.73 percent, at the same time, top line results outshined analysts by $ 0.17 million or 32.08 percent.
Stock Performance
Shares of Viveve Medical, Inc. traded up $ 0.00 or 0.10 percent on Wednesday, reaching $ 0.49 with volume of 265.90 thousand shares. Viveve Medical, Inc. has traded high as $ 0.49 and has cracked $ 0.47 on the downward trend
The closing price of $ 0.49, representing a 16.67 % increase from the 52 week low of $ 0.42 and a 87.27 % decrease over the 52 week high of $ 3.85.
The company has a market capital of $ 7.70 million and is part of the Healthcare sector and Medical Devices industry.
Conference Call
Viveve Medical, Inc. will be hosting a conference call at 5:00 PM eastern time on 12th November 2020, to discuss its 3Q20 financial results with the investment community. The participants may dial, 1-833-255-2833 Toll Free or 1-412-902-6728 Toll Number in order to access the live audio call. A live webcast with presentations will be available on the Internet by visiting the Company website www.viveve.com
Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components.
